ESPR Stock-Based Compensation
Esperion Therapeutics Inc · Stock-Based Compensation
ESPR Stock-Based Compensation
Latest reported$9.91Mperiod ending
ESPR Stock-Based Comp ($0.00 → $9.91M)
Annual stock-based compensation
High-resolution chart · PNG
ESPR stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 9,870,000 | |
| 11,993,000 | |
| 11,958,000 | |
| 15,215,000 | |
| 24,306,000 | |
| 28,385,000 | |
| 25,884,000 | |
| 23,968,000 | |
| 18,605,000 | |
| 15,957,000 | |
| 12,726,000 | |
| 3,679,000 | |
| 1,226,988 | |
| 79,861 | |
| 78,451 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |